ZYME Zymeworks Inc. Common Stock

USD 10.30 -0.17 -1.623687
Icon

Zymeworks Inc. Common Stock (ZYME) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Buy

Average Analyst
Rating
stockTargetAdvisor

Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 10.30

-0.17 (-1.62)%

USD 0.76B

0.39M

USD 14.00(+35.92%)

USD 12.20 (+18.45%)

Icon

ZYME

Zymeworks Inc. Common Stock (USD)
COMMON STOCK | NSD
USD 10.30
0.00 0
Take a Tour
stockTargetAdvisor

Buy

Average Analyst
Rating
stockTargetAdvisor

Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 0.76B

USD 12.20 (+18.45%)

USD 10.30

Zymeworks Inc. Common Stock (ZYME) Stock Forecast

Show ratings and price targets of :
USD 14.00
(+35.92%)

Based on the Zymeworks Inc. Common Stock stock forecast from 3 analysts, the average analyst target price for Zymeworks Inc. Common Stock is USD 14.00 over the next 12 months. Zymeworks Inc. Common Stock’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of Zymeworks Inc. Common Stock is Slightly Bearish, which is based on 3 positive signals and 4 negative signals. At the last closing, Zymeworks Inc. Common Stock’s stock price was USD 10.30. Zymeworks Inc. Common Stock’s stock price has changed by -4.19% over the past week, -20.16% over the past month and +27.16% over the last year.

No recent analyst target price found for Zymeworks Inc. Common Stock
No recent average analyst rating found for Zymeworks Inc. Common Stock

Company Overview Zymeworks Inc. Common Stock

Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a human epidermal growth factor receptor 2 (HER2) that is in Phase 1, Phase ...Read More

https://www.zymeworks.com

108 Patriot Drive, Middletown, DE, United States, 19709

272

December

USD

USA

Adjusted Closing Price for Zymeworks Inc. Common Stock (ZYME)

Loading...

Unadjusted Closing Price for Zymeworks Inc. Common Stock (ZYME)

Loading...

Share Trading Volume for Zymeworks Inc. Common Stock Shares

Loading...

Compare Performance of Zymeworks Inc. Common Stock Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for ZYME

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Zymeworks Inc. Common Stock (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
NVO
Novo Nordisk A/S -1.36 (-1.05%) USD554.45B 46.01 4.80

ETFs Containing ZYME

Symbol Name ZYME's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Zymeworks Inc. Common Stock (ZYME) Stock

Based on ratings from 3 analysts Zymeworks Inc. Common Stock's stock is Buy . Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 1 buy, sell and 2 hold ratings.

Unfortunately we do not have enough data on ZYME's stock to indicate if its a good dividend stock.

Based on targets from 3 analysts, the average taret price for ZYME is USD 14.00 over the next 12 months. The maximum analyst target price is USD 21 while the minimum anlayst target price is USD 10.

ZYME stock's Price/Earning ratio is 2.83. Our analysis grades ZYME stock's Price / Earning ratio at D-. This means that ZYME stock's Price/Earning ratio is above 39% of the stocks in the Biotechnology sector in the NSD exchange. Based on this ZYME may be fairly valued for its sector

The last closing price of ZYME's stock was USD 10.30.

The most recent market capitalization for ZYME is USD 0.76B.

Based on targets from 3 analysts, the average taret price for ZYME is projected at USD 14.00 over the next 12 months. This means that ZYME's stock price may go up by +35.92% over the next 12 months.

We can't find any ETFs which contains Zymeworks Inc. Common Stock's stock.

As per our most recent records Zymeworks Inc. Common Stock has 272 Employees.

Zymeworks Inc. Common Stock's registered address is 108 Patriot Drive, Middletown, DE, United States, 19709. You can get more information about it from Zymeworks Inc. Common Stock's website at https://www.zymeworks.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...